Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-09-30FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic venlafaxine product manufactured by Heritage Pharmaceuticals (d/b/a Avet Pharmaceutica…
-
FDA approval · 2009-09-28FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., updating the approval status of the drug. Th…
-
FDA approval · 2009-09-28FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved the supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc., confirming regulatory approval of…
-
FDA approval · 2009-09-28FDA Approved: CITALOPRAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the generic drug citalopram from Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Benefits of Switching Antidepressants Following Early Nonresponse [Phase 4]
A Phase 4 trial update investigates whether switching antidepressants after early nonresponse benefits patients with depression. Ongoing ass…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-09-28FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine (generic) filed by Chartwell Governmental & Specialty RX, LLC. The approval confirms …
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: Sequenced Treatment Alternatives to Relieve Depression (STAR*D) [Phase 4]
This document reports the completion of the STAR*D Phase 4 clinical trial evaluating sequenced treatment strategies for major depressive dis…
-
CLINICAL_TRIALS trial_result · 2009-09-25Clinical Trial Update: "Assessment of Risk Factors for Depression Treatment at a Safety Net Clinic"
This clinical trial entry (NCT00984685) assesses risk factors influencing depression treatment in a safety-net clinic. The current status is…
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: Pramipexole Versus Placebo in Parkinson's Disease (PD) Patients With Depressive Symptoms [Phase 4]
A Phase 4 trial comparing pramipexole to placebo in Parkinson's disease patients with depressive symptoms reported results. The study result…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Medication Adherence in Older Adults With Serious Mental Illness [NA]
The entry reports completion of a clinical trial evaluating medication adherence in older adults with serious mental illness, including schi…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Treating Alcohol Use In Older Adults With Depression [Phase 4]
A Phase 4 trial update evaluating treatments for alcohol use disorder in older adults with depression; the study sponsored by the US Departm…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia [Phase 2, Phase 3]
A clinical trial evaluated Brief Behavioral Therapy for Insomnia in depressed outpatients with refractory insomnia; the Phase 2 and Phase 3 …
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: Lithium and Standard Therapy in Resistant Depression [Phase 4]
Phase 4 trial evaluating lithium added to standard therapy for treatment-resistant depression; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-09-14Clinical Trial Update: Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL [Phase 1]
Phase 1 PET imaging study to assess central D2 dopamine receptor occupancy by quetiapine (SEROQUEL) in depression; the study has completed.
-
CLINICAL_TRIALS research · 2009-09-14Clinical Trial Update: Correlation Analysis of Hearing Thresholds, Validated Questionnaires and Psychoacoustic Measurements in Tinnitus Patients
A completed study analyzing the relationships between hearing thresholds, validated questionnaires, and psychoacoustic measurements in tinni…
-
CLINICAL_TRIALS trial_result · 2009-09-01Clinical Trial Update: Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
A completed clinical trial evaluating extended-release venlafaxine in elderly patients with depressive disorder and anxiety; sponsored by Wy…
-
FDA approval · 2009-08-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for sertraline hydrochloride from Quallent Pharmaceuticals Health LLC, enabling the generic prod…
-
FDA approval · 2009-08-31FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for the extended-release form of Pristiq (desvenlafaxine succinate).
-
CLINICAL_TRIALS trial_result · 2009-08-28Clinical Trial Update: A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder [Phase 2]
A Phase 2 trial evaluated the effectiveness of R228060 in adults with Major Depressive Disorder; the study has completed.
-
FDA approval · 2009-08-21FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for generic fluoxetine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2009-08-21FDA Approved: CITALOPRAM — Supplemental Application (Cipla USA Inc.)
FDA has approved a supplemental application for Citalopram from Cipla USA Inc.
-
CLINICAL_TRIALS research · 2009-08-20Clinical Trial Update: Modafinil in Treating Fatigue in Patients With Cancer [NA]
A clinical trial is evaluating modafinil for fatigue in cancer patients, sponsored by the University of Virginia. Depression and cognitive/f…
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating DVS-233 SR in combination with venlafaxine ER in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder [Phase 3]
A Phase 3 trial of DVS-233 SR in adult outpatients with Major Depressive Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder [Phase 3]
This update covers a Phase 3 study evaluating DVS-233 SR in combination with Venlafaxine ER for adults with major depressive disorder; the t…